Insider Transactions in Q2 2021 at Syndax Pharmaceuticals Inc (SNDX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 18
2021
|
Fabrice Egros |
SELL
Open market or private sale
|
Direct |
13,609
-24.9%
|
$244,962
$18.65 P/Share
|
|
May 18
2021
|
Fabrice Egros |
BUY
Exercise of conversion of derivative security
|
Direct |
13,609
+17.65%
|
$95,263
$7.54 P/Share
|
|
Apr 26
2021
|
Michael L. Meyers SVP, Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
500
+3.09%
|
$7,500
$15.46 P/Share
|
|
Apr 22
2021
|
Dennis Podlesak |
BUY
Open market or private purchase
|
Direct |
13,967
+24.39%
|
$195,538
$14.11 P/Share
|